ESRX - Express Scripts Holding Company
| Previous Close | 95.80 |
| Open | 95.57 |
| Bid | 0.00 x 2900 |
| Ask | 0.00 x 800 |
| Day's Range | 92.11 - 95.80 |
| 52 Week Range | 66.93 - 101.73 |
| Volume | 31,612,912 |
| Avg. Volume | 6,857,277 |
| Market Cap | 52.037B |
| Beta (3Y Monthly) | N/A |
| PE Ratio (TTM) | 10.69 |
| EPS (TTM) | N/A |
| Earnings Date | Feb 25, 2019 - Mar 1, 2019 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 92.56 |
GuruFocus.com•7 days agoRichard Pzena Exits Express Scripts, Reduces Dover
Richard Pzena (Trades, Portfolio), t he founder and co-chief investment officer of Pzena Investment Management, sold shares of the following stocks during the fourth quarter. Warning! GuruFocus has detected 2 Warning Sign with QSR. The guru closed his Express Scripts Holding Co. (ESRX) stake.
- The Wall Street Journal•17 days ago
[$$] Cigna Says Proposed Drug-Rebate Curbs Will Have Minimal Impact on Earnings
Cigna Corp. said a new federal proposal that would curb rebates from drugmakers would have minimal impact on its results and offered conservative earnings guidance for 2019, the first year it will include the operations of Express Scripts Holding Co. Cigna said that for 2019, it projects adjusted income of $6.2 billion to $6.4 billion, or $16 to $16.50 per share. Analysts wrote that this range was slightly lower than consensus projections, but it included about $200 million, or 40 cents a share, in lingering overhead costs tied to Anthem Inc.’s early exit from its pharmacy-benefit contract with Express Scripts.
Motley Fool•17 days agoCigna Corp (CI) Q4 2018 Earnings Conference Call Transcript
CI earnings call for the period ending December 31, 2018.
- Reuters•17 days ago
Cigna CEO shrugs off concerns about proposed change to rebate rules
The U.S. government's proposal to eliminate rebates that pharmacy benefit managers receive from drugmakers will not have a meaningful impact on growth, and does not affect the commercial market, Cigna Corp Chief Executive Officer David Cordani said on Friday. Investors are worried that Cigna, which closed its $52 billion acquisition of PBM Express Scripts in December, could be hurt by the Trump administration's proposal targeting after-market discounts that middlemen in the pharmaceutical supply chain have received for decades.
- Investor's Business Daily•19 days ago
Anthem Stock Hits Buy Point Intraday On Strong Outlook, Earnings
Anthem stock vaulted higher, touching a buy point intraday, after the company issued a far-better-than-expected profit forecast this year.
- The Wall Street Journal•19 days ago
Anthem's PBM Plans Boost Earnings Expectations
Corp.’s recent acquisition of Express Scripts Holding Co., Anthem’s previous pharmacy-benefit manager, which allowed Anthem to terminate their contract well before the end of 2019, when the break had been expected. Anthem said it will exit the Express Scripts contract on March 1 and begin a yearlong process of transition the next day, with members beginning to migrate in the second quarter. Analysts wrote that the adjusted earnings projection handily beat consensus estimates of around $17.61, with the projected results boosted by several factors including expected membership growth, including in the Medicare Advantage program.
- Moody's•2 months ago
Express Scripts Holding Company -- Moody's confirms Express Scripts at Baa2; stable outlook
This concludes a rating review initiated on March 9, 2018 following the announcement that Cigna Corporation ("Cigna") reached a definitive agreement to acquire Express Scripts in a transaction valued at approximately $67 billion. Moody's changed the direction of the rating review from uncertain to downgrade on September 6, 2018.
- Benzinga•2 months ago
Analysts: Cigna Offers Earnings Growth Potential, But Faces Legal Risks Tied To Aborted Anthem Deal
Cigna Holding Co (NYSE: CI) recently completed its acquisition of pharmacy benefit manager Express Scripts. Raymond James analyst John Ransom upgraded Cigna from Market Perform to Outperform with a $215 price target. Wells Fargo Securities analyst Peter Costa maintained a Market Perform rating for Cigna and lowered the price target from $221 to $200.
- Zacks•2 months ago
5 Great Healthcare Stocks to Buy for 2019
Rapid innovation, major advances and an ageing population have managed to sustain the popularity of healthcare stocks.
- American City Business Journals•2 months ago
'Good for the region': Express Scripts CEO on what's next after the $54 billion Cigna buyout
Express Scripts CEO Tim Wentworth on Thursday sought to calm fears that the company's $54 billion acquisition by insurer Cigna would negatively impact St. Louis.
- Moody's•2 months ago
Connecticut General Life Insurance Company -- Moody's downgrades Cigna's long-term ratings (senior unsecured debt to Baa2); outlook stable
Moody's Investors Service has downgraded Cigna Corporation's long-term ratings, including its senior unsecured debt rating to Baa2 from Baa1, upon the closing of its acquisition of Express Scripts Holding Company (ESI, Baa2, Review Down). Total senior unsecured debt of approximately $41 billion includes $20 billion issued by subsidiary Halfmoon Parent, Inc. (now known as Cigna Corporation), legacy Cigna Corporation (now known as Cigna Holding Company) debt of approximately $5.3 billion and legacy ESI debt of approximately $12.8 billion.
- The Wall Street Journal•2 months ago
[$$] Cigna and Express Scripts Seal $54 Billion Merger
Cigna Corp. completed its $54 billion acquisition of Express Scripts Holding Co., setting up a battle among giant health companies to try to cut health-care costs by managing both medical and drug benefits. The Cigna deal, which won an antitrust nod from the Justice Department without requiring divestitures, brings together a health insurer with a strong focus on employers with a major pharmacy-benefit manager. In an interview, Cigna Chief Executive David Cordani said an initial focus of the combined company will be on ensuring continued smooth business-as-usual operations, but it will begin rolling out new initiatives next year that seek to take advantage of the tie-up between medical and pharmacy oversight, including efforts focused on specialty pharmaceuticals and mental health.
- Reuters•2 months ago
Cigna closes $54 billion purchase of Express Scripts
Cigna Corp (CI.N) on Thursday closed its $54-billion (42.65 billion pounds) deal to buy Express Scripts Holding Co, creating one of the biggest providers of pharmacy benefits and insurance plans in the United States, a combination it says will help it improve healthcare coordination and cut costs. Cigna's deal puts it in direct competition with two other healthcare companies set up the same way - Aetna with CVS Health Corp (CVS.N) and UnitedHealth Group Inc (UNH.N) with Optum. Cigna's deal has already passed antitrust scrutiny.
- American City Business Journals•2 months ago
Express Scripts, Cigna finalize $54 billion merger
Cigna closed on its acquisition of north St. Louis County-based Express Scripts Thursday after receiving final regulatory approval for the $54 billion deal on Wednesday.
Markit•2 months agoSee what the IHS Markit Score report has to say about Express Scripts Holding Co.
This could indicate that investors who seek to profit from falling equity prices are not currently targeting ESRX. Index (PMI) data, output in the Healthcare sector is rising. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way.
- MarketWatch•2 months ago
Celanese stock rises on inclusion to S&P 500
Celanese Corp. shares rose in the extended session Wednesday after S&P Dow Jones Indices said the specialty chemical company would be joining the S&P 500 index . Celanese shares rose 4.8% after hours, following a 0.7% decline to close the regular session at $84.77. S&P said Celanese will trade on the index before the market opens on Monday, replacing Express Scripts Holding Co. which is being acquired by Cigna Corp.
- PR Newswire•2 months ago
Celanese Set to Join S&P 500
NEW YORK , Dec. 19, 2018 /PRNewswire/ -- Celanese Corp. (NYSE: CE) will replace Express Scripts Holding Co. (NASD: ESRX) in the S&P 500 effective prior to the open of trading on Monday, December 24 . S&P ...
- American City Business Journals•2 months ago
Final state approves $54 billion Express Scripts, Cigna merger
On Tuesday, regulators from New Jersey approved the deal, according to a Securities and Exchange (SEC) filing Wednesday. Both Cigna and Express Scripts said they expect to close the transaction Thursday now that all regulatory approvals have been received. Although the combined company will be headquartered in Bloomfield, Connecticut, the Express Scripts headquarters is expected to remain in St. Louis, with Tim Wentworth, president and CEO of the organization, leading the unit.
- ACCESSWIRE•2 months ago
Today's Research Reports on Trending Tickers: Centene and Express Scripts Holding
NEW YORK, NY / ACCESSWIRE / December 18, 2018 / U.S. equities extended losses on Monday as investors await details from the Federal Reserve's final policy meeting of 2018 on Wednesday. The Dow Jones Industrial ...
- Zacks•2 months ago
Here's Why You Should Buy Express Scripts (ESRX) Stock Now
Strong demand for Express Scripts' (ESRX) solutions like SafeGuardRx, 90-day supply for chronic medications, exclusive Accredo Specialty Pharmacy and advanced opioid solutions buoy optimism.
- Insider Monkey•2 months ago
Argentiere Capital’s Returns, AUM and Holdings
Deepak Gulati‘s Argentiere Capital is a Zug, Switzerland-based hedge fund launched back in June 2013, with an additional office in Chicago. The fund is focused on offering its services to pooled investment vehicles and manages separate client-focused equity portfolios. It’s run by a team of former members of JP Morgan’s Global Equities Proprietary Trading Group […]
- American City Business Journals•2 months ago
Only one state stands in the way of $54B Cigna/Express Scripts deal
Only one state stands in the way of approving the $54 billion merger between Cigna and Express Scripts after government authorities in California and New York signed off on the deal Thursday. Both California's Department of Managed Health Care and New York's Department of Financial Services approved the deal and listed a set of conditions the companies agreed to. Conditions to the transaction in California Conditions to the transaction in New York Per the California approval, Cigna and Express Scripts agree to not increase premiums as a result of acquisition costs, and keep premium rate increases to a minimum.
Zacks•2 months agoIs Express Scripts Holding (ESRX) Stock Outpacing Its Medical Peers This Year?
Is (ESRX) Outperforming Other Medical Stocks This Year?
